December 2024 Br J Cardiol 2024;31:144–9 doi:10.5837/bjc.2024.053
Lisa W M Leung, Zaki Akhtar, Oswaldo Valencia, Genevieve Shouls, Rabia Warraich, Jennifer Vara, Sue Jones, Pamala Kanagasabapathy, Mark M Gallagher, Nesan Shanmugam
Introduction There is a wide range of cardiac conditions that may significantly increase the risk of sudden cardiac death (SCD). They range from ischaemic heart disease to inherited cardiac conditions, such as hypertrophic obstructive cardiomyopathy, and these may be in the setting of primary or secondary prevention. Potential device candidates are expected to have a reasonable life-expectancy of at least one year.1 While clear guidelines help cardiologists and their multi-disciplinary teams to steer the right patients forward for a defibrillator device and to the right type, it is recognised that it may be difficult to assess the frailty of
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits